Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Microsoft PowerPoint - Digitial Displays 11324 [Compatibility Mode] Amyloidosis 2024 - Update on Best Practices for Early Detection and Treatment Washington University School of Medicine in St. Louis - Continuing Medical Education (314) 362-6891 (800) 325-9862 Website: https://cme.wustl.edu Email: cme@wustl.edu For information and to register Course Website …
compliance 66 OI | Vol. 39, No. 1, 2024 | accc-cancer.org T his article outlines coding changes specific to the International Classifica-tion of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), Current Procedural Terminology (CPT®), and the Healthcare Common Procedure Coding System (HCPCS) for services that may be provided by or related to services by oncology …
Duke Cancer Institute improved patient access and reduced healthcare utilization by implementing e-consults for patients experiencing endocrine immune-related adverse events.
Oncology Hematology Care, Inc. launched a one-year quality improvement project to implement and standardize comprehensive biomarker testing in patients with metastatic non-small cell lung cancer.
ACCC rebrands: these changes were made to represent the strength of its multidisciplinary membership and prepare ACCC for the next 50 years of innovation, education, and advocacy.
79 spotlight Along the corridors of the Medical Mile in Grand Rapids, Michigan, sits Lemmen-Holton Cancer Pavilion, the main campus of Corewell Health–West. The six-story building is one of the cancer pro- gram’s 6 locations across Northwest Michigan. Through its doors, patients with cancer can access the only adult blood and marrow transplant department on the west side of the state. This …
Embedding counseling services into oncology and palliative care across 6 clinic locations landed this program a 2023 ACCC Innovator Award. Learn how this model allows patients to receive psychosocial care from treatment through survivorship.
Discover how St. Elizabeth Cancer Center launched a comprehensive program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.
ACCC PRESIDENT’S MESSAGE 3 Coming in Your 2024 ONCOLOGY ISSUES cutting-edge practices. And perhaps most importantly, we’ve fostered a culture of continu- ous learning and innovation within our organization. However, our work is far from over. The landscape of oncology care continues to evolve at a rapid pace, demanding even greater adaptability and agility from our workforce. As …
ISSUES ONCOLOGY Implementing e-consults for immune-related adverse events | 30 Standardizing comprehensive biomarker testing in non-small cell lung cancer | 20 Creating an advanced practice radiation therapist role | 10 This publication is a benefit of membership Association of Community Cancer Centers Vol. 39 | No. 1 | 2024 Collaborative Care: A Model for Embedding Counseling …
tools 84 OI | Vol. 39, No. 1, 2024 | accc-cancer.org fulvestrant for adult patients with hormone receptor-positive (HR+)/HER2–, locally advanced or metastatic breast cancer with 1 or more PIK3CA/AKT1/PTEN-alterations as detected by an FDA-approved test following progression on at least 1 endocrine-based regimen in the metastatic setting or recurrence on or within 12 months of completing …
February 28, 2024
The ACCC 50th Annual Meeting & Cancer Center Business Summit (AMCCBS) offers countless opportunities to collaborate, grow, and transform. Executives from across the health care leadership community will come together on February 28 – March 1, 2024, at the Capital Hilton in Washington, DC, to explore cutting-edge solutions to persistent challenges and navigate our shifting cancer care …
Association of Community Cancer Centers Association of Community Cancer Centers Treasurer’s Report to the Board of Trustees Financial Reports for December 2023 Douglas B. Flora, MD, LSSBB Variance Report Membership Renewals: As of the end of December, 530 Cancer Program Members (or 84.4%) have renewed their membership and 114 Individual Members (or 51.8%) have renewed. The budget …
ESHOS 2024 Review of SABCS Saturday March 9th, 2024 The Lux Hotel and Conference Center Waterloo NY Attendee Roster First Name Last Name Title Account Name Trish Casillo Oncology Account Specialist AstraZeneca Melissa Sullivan Senior Oncology Account Specialist AstraZeneca Camille Zynda Medical Science Liaison AstraZeneca Ashley Camarata Medical Staff Recruiter Bassett …
ACCCBuzz spoke with the co-directors of a precision medicine Initiative at the Sidney Kimmel Cancer Center at Jefferson Health in Philadelphia, Pennsylvania about their work in building a team to champion EHR integration to support precision medicine.
IOS-IA 2024 Spring Conference Friday March 8th, 2024 Marriot Des Moins Downtown Hotel Des Moins IA Attendee Roster First Name Last Name Title Account Name Javier Leaniz AbbVie Inc. Daphne Hao Management Development Program AbbVie Inc. Justin Hayne Senior Medical Science Liaison AbbVie Inc. Scott Vance Hematology Account Executive AbbVie Inc. Anthony Belott Chief Development …
Women Thought Leaders in Oncology Saturday March 9th, 2024 Loews Vanderbuilt Nashville TN Attendee Roster First Name Last Name Title Account Name Louise Cayabyab Director, Thought Leader Liaison Southeast Acrotech Biopharma Reggie Glaspie Amgen Oncology Portfolio Manager Amgen Oncology Keely Martin Amgen Oncology Amanda Impellizzeri Executive Director Association of Community …
ASSOCIATION OF CANCER CARE CENTERS 1 Financial Advocacy Services Guidelines Assessment Tool User Guide ASSOCIATION OF CANCER CARE CENTERS Domains Covered in the Assessment STEP 1 - PREPARE • Be prepared to spend 30-45 minutes completing the assessment (additional time may be needed to collect information prior to submission). • This is an organizational assessment …
A GUIDE TO OPTIMIZING THE ROLE OF LIQUID BIOPSY ASSOCIATION OF CANCER CARE CENTERS In 2020, the US Food and Drug Administration (FDA) approved the first set of liquid biopsy companion diagnostic tests for patients with advanced cancers who may be eligible for targeted therapy.1 Since then, a host of liquid biopsy tests have emerged. While the phrase “liquid biopsy” may …
The interpretation of multigene next-generation sequencing (NGS) tests can be complex, especially when the test report indicates tumoral heterogeneity or subclonal mutations. Actionable genomic alterations may include somatic gene rearrangements, deletions, insertions, fusions, exxon skipping, single nucleotide change, and copy number of variants. Germline pathogenic variants …